The Okyanos educational library on adult stem cell therapy is intended to provide patients and others interested with basic, understandable information on the history, science and uses of stem cells and other related subjects. The cardiac stem cell therapy field is advancing as a result of accelerated research into the use of adult stem cells and clinical trials.
Read Dr. Walpole’s paper in the Cath Lab Digest on currently known methods, and the pros and cons of each, of adult stem cell delivery to cardiac tissue in the treatment of heart disease.
Cell therapy that utilizes adult stem cells from the patient’s own body promises to be the next evolution in medicine based on its safety profile, regenerative benefits, repair potential and wide applicability.
Stem cell research began in the 1800′s. In 2001, researchers discovered that fat tissue contains the most abundant source of stem cells in the body. This advance is what has made Okyanos cell therapy possible.
Mesenchymal Stem Cells, (MSC) are analogous to a drugstore that functions at the local site of injury by providing different types of “medications”. Mescenchymal cells also respond and communicate with the local environmental needs to provide the correct “medications” that are required for healing.
Treatments for cardiovascular diseases are aimed at providing sufficient blood and nutrient supply to the entire heart muscle. A groundbreaking way to achieve this result is to have stem cells from your own body grow new blood vessels in the heart – a process known as angiogenesis.
Both the European Union and United States have rigorous standards to ensure the quality and safety of medical devices and drugs. While EU approval is typically faster than FDA approval, research has shown that the EU approval process does not sacrifice safety for speed.